Sort
51,593 grants matching “hepatitis”
INVESTIGATION OF ERBB SIGNALING IN COLORECTAL CANCER DURING LIVER METASTASIS
$408,312David W. Threadgill · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA
Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism
$408,310Robert E Fleming · Saint Louis University · R01 · FY2015 · DK
Cyclin D1/CDK4 Complex in Hepatocyte Proliferation
$408,309Jeffrey H Albrecht · Hennepin Healthcare Research Institute · R01 · FY2014 · DK
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
$408,299Mehmet Sofuoglu · Yale University · R01 · FY2013 · DA
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus
$408,288Stanley M Lemon · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
Role of chitinase-3-like-1 (Chi3l1) in acetaminophen-induced liver injury
$408,270Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · DK
FUNCTION OF THE HEMOCHROMATOSIS PROTEIN
$408,232Caroline Enns · Oregon Health & Science University · R01 · FY2009 · DK
Role of NgBR in Hepatic Steatosis
$408,222Qing Miao · Nyu Long Island School Of Medicine · R01 · FY2021 · DK
Myeloid FoxO1 in Lipid Metabolism
$408,222Hengjiang Henry Dong · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus
$408,220Stanley M Lemon · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Role of Uhrf1 in Liver Development, Regeneration and Carciogenesis
$408,198Chinweike Ukomadu · Brigham And Women'S Hospital · R01 · FY2010 · DK
HUMAN LIVER CYTOCHROMES P450
$408,155California Toxicology Research Institute · R01 · FY2002 · GM
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
$408,139Robert A Schnoll · University Of Pennsylvania · R01 · FY2020 · CA
Core D: Clinical Sciences
$408,139Jeffrey M Jacobson · Case Western Reserve University · P30 · FY2023 · AI
AAV vectors for prevention and therapy of HCV infection
$408,128Research Inst Nationwide Children'S Hosp · R01 · FY2005 · AI
Models for Optimal Liver Transplant Outcomes
$408,122Mayo Clinic · R01 · FY2005 · DK
Models for Optimal Liver Transplant Outcomes
$408,122Mayo Clinic · R01 · FY2004 · DK
Mechanisms of insulin secretion mediated by alpha cells
$408,119Jonathan E Campbell · Duke University · R01 · FY2023 · DK
HCV Disease Management in HIV- HCV Coinfected IDUs
$408,118Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2012 · DA
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
$408,073Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2018 · ES
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
$408,062Arash Grakoui · Emory University · U19 · FY2022 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 1
$408,062Naglaa H. Shoukry · Emory University · U19 · FY2022 · AI
Correlates of protective immunity to HCV and rational vaccine design: Clinical Core
$408,062Naglaa H. Shoukry · Emory University · U19 · FY2022 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 2
$408,061Arash Grakoui · Emory University · U19 · FY2022 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 3
$408,060Rama Rao Amara · Emory University · U19 · FY2022 · AI